Physician profile
Maximilian Evers
NPI 1891292934
$3,362.27
in general payments reported to CMS, 2019-2025
8 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $522 · 2024: $2,472 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Travel and Lodging: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.32 |
| Travel and Lodging | $1,252.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,283.90 | 2023-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered |
| Inari Medical, INC. | $451.80 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $274.12 | 2024-2025 | Indigo System |
| Sirtex Medical INC | $153.53 | 2023 | Sir-Spheres Microspheres |
| Medtronic, INC. | $81.64 | 2023 | Intellis Adaptivestim, Concertotm |
| Ethicon US, LLC | $46.57 | 2024 | Neuwave |
| Stryker Corporation | $41.50 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Mozarc Medical US LLC | $29.21 | 2025 | Palindrome |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maximilian Evers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.